Akebia Therapeutics Inc (NASDAQ:AKBA)

12.30
Delayed Data
As of 3:59pm ET
 +0.145 / +1.19%
Today’s Change
2.99
Today|||52-Week Range
13.17
+94.54%
Year-to-Date
No recent news for Akebia Therapeutics Inc.

Today’s Trading

Previous close12.15
Today’s open12.14
Day’s range11.73 - 12.40
Volume190,220
Average volume (3 months)1,647,274
Market cap$1.7B
Data as of 3:59pm ET, 05/27/2020

Growth & Valuation

Earnings growth (last year)+4.52%
Earnings growth (this year)+38.19%
Earnings growth (next 5 years)+15.80%
Revenue growth (last year)+61.26%
P/E ratioNM
Price/Sales2.23
Price/Book3.75

Competitors

 Today’s
change
Today’s
% change
LGNDLigand Pharmaceutica...-1.21-1.14%
ZYMEZymeworks Inc+0.80+2.09%
TBPHTheravance Biopharma...-1.58-5.92%
ZGNXZogenix Inc-0.54-1.78%
Data as of 4:00pm ET, 05/27/2020

Financials

Next reporting dateAugust 5, 2020
EPS forecast (this quarter)-$0.48
Annual revenue (last year)$335.0M
Annual profit (last year)-$279.7M
Net profit margin-83.48%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts